SAT-LB076 T2-Signal Intensity, SST Receptor Expression and First-Generation Somatostatin Analogues Efficacy Predict Hormone and Tumor Responses to Pasireotide in Acromegaly

Background: Previous studies indicate that PAS-LAR can achieve control of insulin-like growth factor I (IGF-I) levels and may reduce tumor size, however a subset of acromegaly patients responds poorly. T2-signal intensity, somatostatin receptor (SST) subtype 2 and 5 expression, and the response to f...

Descripción completa

Detalles Bibliográficos
Autores principales: Coopmans, Eva, Schneiders, Joppe, El-Sayed, Nour, Muhammad, Ammar, Hofland, Leo, Petrossians, Patrick, Lelij, Aart., Neggers, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552185/
http://dx.doi.org/10.1210/js.2019-SAT-LB076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552185/
http://dx.doi.org/10.1210/js.2019-SAT-LB076

Ejemplares similares